373 related articles for article (PubMed ID: 12938057)
21. [Prophylactic treatments of migraine].
Massiou H
Rev Neurol (Paris); 2000; 156 Suppl 4():4S79-86. PubMed ID: 11139754
[TBL] [Abstract][Full Text] [Related]
22. Placebo efficacy in childhood and adolescence migraine: an analysis of double-blind and placebo-controlled studies.
Evers S; Marziniak M; Frese A; Gralow I
Cephalalgia; 2009 Apr; 29(4):436-44. PubMed ID: 19170687
[TBL] [Abstract][Full Text] [Related]
23. [Spanish study of quality of life in migraine (II). Profile of medication consumption and subjective efficacy].
Pascual J; Leira R; Láinez JM; Alberca R; Titus F; Morales F; Díez-Tejedor E; García de Polavieja J
Neurologia; 1999 May; 14(5):204-9. PubMed ID: 10377720
[TBL] [Abstract][Full Text] [Related]
24. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Diener HC; Gendolla A; Gebert I; Beneke M
Headache; 2005; 45(7):874-82. PubMed ID: 15985104
[TBL] [Abstract][Full Text] [Related]
25. Drug treatment of migraine: Part II. Preventive therapy.
Noble SL; Moore KL
Am Fam Physician; 1997 Dec; 56(9):2279-86. PubMed ID: 9402813
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and tolerability of sumatriptan injection for the treatment of morning migraine: two multicenter, prospective, randomized, double-blind, controlled studies in adults.
Winner P; Adelman J; Aurora S; Lener ME; Ames M
Clin Ther; 2006 Oct; 28(10):1582-91. PubMed ID: 17157114
[TBL] [Abstract][Full Text] [Related]
27. Current therapies in childhood and adolescent migraine.
Pakalnis A
J Child Neurol; 2007 Nov; 22(11):1288-92. PubMed ID: 18006958
[TBL] [Abstract][Full Text] [Related]
28. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R;
Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
[TBL] [Abstract][Full Text] [Related]
29. [Pharmacologic treatment of acute migraine attack in children].
Cuvellier JC; Joriot S; Auvin S; Vallée L
Arch Pediatr; 2005 Mar; 12(3):316-25. PubMed ID: 15734131
[TBL] [Abstract][Full Text] [Related]
30. Rofecoxib in the acute treatment of migraine: a randomized controlled clinical trial.
Saper J; Dahlof C; So Y; Tfelt-Hansen P; Malbecq W; Loeys T; Barraclough E; Klipfel M; Lines C; Visser H; Reines S; Yuen E;
Headache; 2006 Feb; 46(2):264-75. PubMed ID: 16492236
[TBL] [Abstract][Full Text] [Related]
31. Preventive treatment of migraine.
Silberstein SD
Rev Neurol Dis; 2005; 2(4):167-75. PubMed ID: 16622394
[TBL] [Abstract][Full Text] [Related]
32. Guidelines on migraine: part 5. Recommendations for specific prophylactic drugs.
Morey SS
Am Fam Physician; 2000 Dec; 62(11):2535-9. PubMed ID: 11130237
[No Abstract] [Full Text] [Related]
33. Prophylactic Drug Treatment of Migraine in Children and Adolescents: An Update.
Tajti J; Szok D; Csáti A; Vécsei L
Curr Pain Headache Rep; 2016 Jan; 20(1):1. PubMed ID: 26695061
[TBL] [Abstract][Full Text] [Related]
34. Sumatriptan nasal spray in the acute treatment of migraine in adolescents and children.
Callenbach PM; Pels LP; Mulder PG; Linssen WH; Gooskens RH; van der Zwan JL; Brouwer OF;
Eur J Paediatr Neurol; 2007 Nov; 11(6):325-30. PubMed ID: 17428708
[TBL] [Abstract][Full Text] [Related]
35. Incidence and determinants of migraine prophylactic medication in the Netherlands.
Rahimtoola H; Buurma H; Tijssen CC; Leufkens HG; Egberts AC
Eur J Clin Pharmacol; 2002 May; 58(2):149-55. PubMed ID: 12012149
[TBL] [Abstract][Full Text] [Related]
36. [The treatment of migraine].
Titus F
Rev Neurol; 1997 Feb; 25(138):295-300. PubMed ID: 9147762
[No Abstract] [Full Text] [Related]
37. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
Dowson AJ; Massiou H; Lainez JM; Cabarrocas X
Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
[TBL] [Abstract][Full Text] [Related]
38. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society.
Lewis D; Ashwal S; Hershey A; Hirtz D; Yonker M; Silberstein S; ;
Neurology; 2004 Dec; 63(12):2215-24. PubMed ID: 15623677
[TBL] [Abstract][Full Text] [Related]
39. Migraine: a pharmacologic review with newer options and delivery modalities.
Baumel B
Neurology; 1994 May; 44(5 Suppl 3):S13-7. PubMed ID: 7911231
[TBL] [Abstract][Full Text] [Related]
40. Weight change associated with the use of migraine-preventive medications.
Taylor FR
Clin Ther; 2008 Jun; 30(6):1069-80. PubMed ID: 18640463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
